SCHEMBL78840

SCHEMBL78840

[CH2]CC(C)(C)CCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL306916 0.95 TSHR (0.32)
SCHEMBL1973779 0.92 TSHR (0.37)
SCHEMBL13583489 0.89 TSHR (0.42)
SCHEMBL3341692 0.89 TSHR (0.42)
SCHEMBL1971804 0.89 TSHR (0.42)
SCHEMBL10758322 0.89 TSHR (0.42)
SCHEMBL8755240 0.89 TSHR (0.42)
SCHEMBL22749064 0.89 TSHR (0.42)
SCHEMBL1971557 0.89 TSHR (0.42)
SCHEMBL1176711 0.89 TSHR (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 739 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2433937-B1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof PURDUE PHARMA LP (US) 2016-06-29 EP claimed
EP-2086958-B1 SUBSTITUTED-QUINOXALINE-TYPE-PIPERIDINE COMPOUNDS AND THE USES THEREOF PURDUE PHARMA LP (US) 2015-01-14 EP claimed
CN-101878208-B Substituted-quinoxaline-type-piperidine compounds and the uses thereof PURDUE PHARMA L.P. (US) 2014-10-15 CN claimed
CN-114364405-B Prostate Specific Membrane Antigen (PSMA) inhibitors as diagnostic and radionuclide therapeutics 五一一制药股份有限公司 2024-07-16 CN disclosed
WO-2024121253-A1 NOVEL N,N-DIMETHYLTRYPTAMINE (DMT) DERIVATIVES AND USES THEREOF MIHKAL GMBH (CH) 2024-06-13 WO disclosed
CN-111372916-B Process for producing dipyrrolidine compounds 巴斯夫欧洲公司 2024-03-26 CN disclosed
CN-113861049-B CO (carbon monoxide) 2 Solubilizing viscosity reducer and preparation method and application thereof 中国石油化工股份有限公司 2024-03-22 CN disclosed
EP-4112053-B1 TREATMENT OF SYNUCLEINOPATHIES DEUTSCHES ZENTRUM FUER NEURODEGENERATIVE ERKRANKUNGEN E V DZNE (DE) 2024-02-14 EP disclosed
US-20240024252-A1 LIPID NANOPARTICLE NITTO DENKO CORPORATION (JP) 2024-01-25 US disclosed
WO-2024018762-A1 PH-SENSITIVE CATIONIC LIPID AND LIPID NANOPARTICLE 国立大学法人北海道大学 2024-01-25 WO disclosed
WO-2024018761-A1 NEUTRAL LIPID AND LIPID NANOPARTICLE 国立大学法人北海道大学 2024-01-25 WO disclosed
EP-0232776-A2 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI2 derivatives TORAY INDUSTRIES, INC. (JP) 1987-08-19 EP disclosed
US-4549992-A Antihypertensive amides USV PHARMACEUTICAL CORP. (US) 1985-10-29 US disclosed
US-4404372-A 15-Substituted-ω-pentanorprostaglandin derivatives PFIZER INC. (US) 1983-09-13 US disclosed
US-4342868-A 2-Descarboxy-2-(tetrazol-5-yl)-16,16-dimethyl-17-(2-furyl)-ω-trisnorprostaglandin E2 PFIZER INC. (US) 1982-08-03 US disclosed
EP-0004577-B1 PROCESS FOR PREPARING 2,2-DIMETHYLOL ALKANALS BAYER AG (DE) 1980-10-01 EP disclosed
US-4188403-A Cyclopentan-1-amines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1980-02-12 US disclosed
EP-0004577-A2 Process for preparing 2,2-dimethylol alkanals BAYER AG (DE) 1979-10-17 EP disclosed
US-4122290-A FORMALDEHYDE REACTED WITH AN ALDEHYDE, 2,2-DIMETHYLOLALKANE HYDROGENATED BAYER AKTIENGESELLSCHAFT (DE) 1978-10-24 US disclosed
US-3932487-A HYPOTENSIVE MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) 1976-01-13 US disclosed